| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | Taiwan | 4 | |
| #3 | Australia | 3 | |
| #4 | China | 2 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | Republic of Korea | 2 | |
| #7 | Brazil | 1 | |
| #8 | Canada | 1 | |
| #9 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Macromolecular chemistry and polymers |
| # | Name | Total Patents |
|---|---|---|
| #1 | Yang David J | 13 |
| #2 | Chang Wei-Chung | 11 |
| #3 | Tsao Ning | 9 |
| #4 | Kuo Tsung-Tien | 8 |
| #5 | Ke Chi-Shiang | 6 |
| #6 | Chung Min-Ching | 6 |
| #7 | Kuo Tsung Tien | 3 |
| #8 | Chen Ping-Fan | 2 |
| #9 | Huang Hung-Yuan | 2 |
| #10 | Chang Kai-Chi | 2 |
| Publication | Filing date | Title |
|---|---|---|
| US2020085978A1 | Composition for cross talk between estrogen receptors and cannabionoid receptors | |
| US2018264125A1 | Glycopeptide composition | |
| US2018326101A1 | Compound and pharmaceutical composition for targeted drug delivery | |
| US2018296707A1 | Pharmaceutical formulation and method of preparing the same | |
| US10016520B1 | Compound and pharmaceutical composition for tumor imaging and tumor therapy |